THYMOSIN IN THE EARLY DIAGNOSIS AND TREATMENT OF HIGH RISK HOMOSEXUALS AND HEMOPHILIACS WITH AIDS‐LIKE IMMUNE DYSFUNCTION<sup>a</sup>

Paul H. Naylor(Wayne State University), Allan L. Goldstein(George Washington University), Fred Darr(American Red Cross), Paul R. McCurdy(Centers for Disease Control and Prevention), Gary L. Simon(George Washington University), Thomas J. Spira(World Health Organization - Pakistan), Marcelo B. Sztein(University of Maryland, Baltimore), Richard S. Schulof(George Washington University), Craig M. Kessler(Georgetown University)

Annals of the New York Academy of Sciences

December 1, 1984

10.1111/j.1749-6632.1984.tb37125.x

Cited by 20

Related Papers

Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial

|The Lancet|2008|862

Long-Term, Low-Intensity Warfarin Therapy for the Prevention of Recurrent Venous Thromboembolism

|New England Journal of Medicine|2003|809

Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial

|JAMA|1995|605

A Prospective Study of Human Immunodeficiency Virus Type 1 Infection and the Development of AIDS in Subjects with Hemophilia

|New England Journal of Medicine|1989|528

Serum Levels of the Proinflammatory Cytokines Interleukin-1 Beta (IL-1β), IL-6, IL-8, IL-10, Tumor Necrosis Factor Alpha, and IL-12(p70) in Malian Children with Severe<i>Plasmodium falciparum</i>Malaria and Matched Uncomplicated Malaria or Healthy Controls

|Infection and Immunity|2004|447